ELOVL6 and Alzheimer disease: On the other hand, a recent study by Berdyshev et al. showed that the expression levels of ELOVL3 and ELOVL6 were significantly decreased in the skin of human AD patients and IL-13 transgenic AD model mice, although ELOVL1 and ELOVL4 were increased [87].